Market
How will the $190M pediatric cancer research funding be allocated by June 30, 2025?
3
Resolution / Starting Odds
Majority to existing programs • 25%
Majority to new initiatives • 25%
Even split between existing and new • 25%
Other allocation strategy • 25%
Official reports or announcements from the National Institutes of Health or relevant agencies
Story
Senate Passes $190M Pediatric Cancer Research Bill, Initially Passed 384-4 by House on March 5, 2024
Dec 20, 2024, 07:42 PM
The pediatric cancer research funding bill, known as H.R. 3391 - Gabriella Miller Kids First Research Act 2.0, was passed by the Republican-controlled House on March 5, 2024, with an overwhelming vote of 384-4. However, the bill has been stalled in the Democrat-controlled Senate, led by Majority Leader Chuck Schumer, since it was received on March 6, 2024. Critics have pointed out that Democrats have blamed Republicans, including Elon Musk, for the lack of funding, despite the fact that the bill was already approved in the House. Recently, the Senate voted to pass the bill after months of delays, and it is now set to be sent to President Biden for final approval. The passage of the bill comes amid ongoing political debates regarding funding priorities, with some Democrats accusing Republicans of prioritizing tax cuts over essential funding for children's cancer research.
View original story
Similar markets
Passed • 25%
Rejected • 25%
No Action • 25%
Amended • 25%
Genetic research • 25%
Other • 25%
Data infrastructure • 25%
Clinical trials • 25%
Yes • 50%
No • 50%
Change Allocation • 25%
Decrease Funding • 25%
Increase Funding • 25%
No Amendments • 25%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
Neutral • 25%
Supportive • 25%
No Statement • 25%
Opposed • 25%
No • 50%
Yes • 50%
Yes • 50%
No • 50%
Supportive • 25%
No official stance • 25%
Neutral • 25%
Opposed • 25%
Minority of states implement changes • 25%
Majority of states implement changes • 25%
Federal government mandates changes • 25%
No state-level changes • 25%